4849 studies found for:    Lung Neoplasms
Show Display Options
Rank Status Study
1 Completed
Has Results
Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Dysgeusia;   Taste Disorders;   Lung Neoplasms;   Small Cell Lung Carcinoma
Intervention:
2 Unknown  Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours
Conditions: Lung Neoplasms;   Lung Cancer
Intervention: Procedure: Fractionated Stereotactic Radiotherapy
3 Completed FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Intervention: Drug: FR901228
4 Completed
Has Results
Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Chemotherapy-Induced Thrombocytopenia;   Non-Small Cell Lung Cancer;   Cancer;   Lung Neoplasms;   Oncology;   Solid Tumors;   Thrombocytopenia
Interventions: Biological: Romiplostim;   Drug: Placebo;   Drug: Gemcitabine;   Drug: Carboplatin;   Drug: Cisplatin
5 Completed A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer
Conditions: Carcinoma, Non-Small Cell-Lung;   Lung Neoplasms;   Lung Cancer;   Respiratory Tract Neoplasms
Interventions: Biological: AV-299 + gefitinib;   Drug: Gefitinib
6 Completed Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer
Conditions: Adenocarcinoma;   Non-Small-Cell Lung Carcinoma;   Lung Neoplasms
Intervention: Drug: Motexafin Gadolinium
7 Completed Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Conditions: Recurrent Colon Cancer;   Extensive Stage Small Cell Lung Cancer;   Stage III Pancreatic Cancer;   Stage III Rectal Cancer;   Limited Stage Small Cell Lung Cancer;   Recurrent Pancreatic Cancer;   Recurrent Rectal Cancer;   Stage III Non-small Cell Lung Cancer;   Stage I Pancreatic Cancer;   Stage II Non-small Cell Lung Cancer;   Stage IVB Pancreatic Cancer;   Stage II Pancreatic Cancer;   Stage III Colon Cancer;   Stage IVA Pancreatic Cancer
Interventions: Drug: Detox-B adjuvant;   Drug: ras peptide cancer vaccine
8 Not yet recruiting Circulating Tumor Cells Using the ClearCell® FX EP+ System During the Course of Treatment for Lung Cancer
Conditions: Lung Cancer;   Lung Neoplasms;   Cancer of Lung;   Cancer of the Lung;   Neoplasms, Lung;   Neoplasms, Pulmonary;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Non-small-cell Lung;   Adenocarcinoma;   Squamous Cell Carcinoma
Intervention:
9 Withdrawn GRN1005 for Brain Metastases From Breast or Lung Cancer
Conditions: Breast Cancer;   Lung Neoplasms;   Breast Neoplasms;   Lung Cancer
Interventions: Drug: Trastuzumab;   Drug: GRN 1005
10 Unknown  Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
Conditions: Non Small Cell Lung Cancer;   Lung Cancer;   Stage IIIA Non Small Cell Lung Cancer;   Stage IIIB Non Small Cell Lung Cancer
Intervention: Drug: S-3304
11 Not yet recruiting Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients
Conditions: Lung Neoplasms;   Lung Cancer
Intervention: Radiation: Radiation therapy
12 Completed Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
Conditions: Lung Cancer;   Non-Small Cell Lung Cancer;   Small Cell Lung Cancer
Intervention: Procedure: Exhaled Breath Sampling
13 Recruiting Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
Conditions: Adenocarcinoma of the Lung;   Extensive Stage Small Cell Lung Cancer;   Limited Stage Small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Intervention: Drug: Ponatinib
14 Completed Lung Cancer Informational Study (LCIS)
Conditions: Cancer;   Enhanced Care;   Decision-Making;   Advance Lung Cancer;   Stage III Lung Cancer;   Stage IV Lung Cancer
Interventions: Behavioral: Enhance Care;   Behavioral: Usual Care
15 Active, not recruiting Study of Arsenic Trioxide in Small Cell Lung Cancer
Conditions: Lung Cancer;   Cancer of Lung;   Pulmonary Cancer;   Pulmonary Neoplasms;   Carcinoma, Small Cell
Intervention: Drug: Arsenic Trioxide
16 Completed Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer
Conditions: Non-Small-Cell Lung Carcinoma;   Carcinoma, Non-Small Cell Lung;   Lung Neoplasms
Intervention: Drug: EKB-569
17 Recruiting Irreversible Electroporation(IRE) For Lung Neoplasms Accompanied by Respiratory Function Insufficiency
Condition: Lung Neoplasms Accompanied by Respiratory Function Insufficiency
Interventions: Procedure: Irreversible electroporation (IRE);   Device: NanoKnife
18 Completed Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
Conditions: Lung Neoplasm;   Carcinoma Non-small Cell Lung Cancer Stage IIIA;   Carcinoma Non-small Cell Lung Cancer Stage IIIB;   Carcinoma Non-small Cell Lung Cancer Stage IV
Interventions: Biological: Lucanix™;   Other: Placebo Comparator
19 Completed
Has Results
Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer
Conditions: Lung Neoplasms;   Carcinoma;   Cancer of the Lung;   Non-Small-Cell Lung Carcinoma
Interventions: Drug: Cetuximab;   Drug: Cisplatin;   Drug: Vinorelbine
20 Recruiting Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase II
Conditions: Non-small Cell Lung Cancer;   Advanced Non-small Cell Lung Cancer;   Recurrent Non-small Cell Lung Cancer
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Hydroxychloroquine;   Drug: Bevacizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years